Open access · US-GOV via ClinicalTrials.gov Clinical trial

A Prospective, Study Evaluating the Efficacy of DOSE Formulations in Treatment of Melasma and Cutaneous Signs of Aging

Authors not listed

Goldman, Butterwick, Fitzpatrick and Groff · 2019

Epigenetic alterations Human Randomized controlled trial

Abstract

The primary objective is to evaluate the efficacy, of D.O.S.E formulations in the treatment of melasma and cutaneous signs of aging.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source: ClinicalTrials.gov
Canonical: link ↗
Fetched: 2026-05-31 MST

Cite this

APA

Anonymous. (2019). A Prospective, Study Evaluating the Efficacy of DOSE Formulations in Treatment of Melasma and Cutaneous Signs of Aging. <em>Goldman, Butterwick, Fitzpatrick and Groff</em>. https://clinicaltrials.gov/study/NCT04137263

Vancouver

Anonymous. A Prospective, Study Evaluating the Efficacy of DOSE Formulations in Treatment of Melasma and Cutaneous Signs of Aging. Goldman, Butterwick, Fitzpatrick and Groff. 2019.

BibTeX

@misc{anon2019AProsp, title = {A Prospective, Study Evaluating the Efficacy of DOSE Formulations in Treatment of Melasma and Cutaneous Signs of Aging}, author = {Anonymous}, journal = {Goldman, Butterwick, Fitzpatrick and Groff}, year = {2019}, }